Skip to main content

Home/ Cerebral Palsy/ Group items tagged protein pump inhibitor

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Lee Vander Loop

To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Ero... - 0 views

www.clinicaltrials.gov/...NCT00992589

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease protein pump inhibitor reflux GERD study Rabeprazole PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
Lee Vander Loop

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants - 0 views

www.clinicaltrials.gov/...NCT00888017

gastroesophageal reflux protein pump inhibitor gastroesophageal reflux disease antacids and neonates antacid contradiction in neonates clinical trial clinical trials reflux GERD antacids PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Objective is to determine if a connection exists between proton pump inhibitor antacids and decreased rate of bone mineralization in neonates
1 - 2 of 2
Showing 20▼ items per page